当前位置: X-MOL 学术Aliment. Pharm. Ther. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Prothrombin induced by vitamin K absence or antagonist-II and alpha foetoprotein to predict development of hepatocellular carcinoma in Caucasian patients with hepatitis C-related cirrhosis treated with direct-acting antiviral agents
Alimentary Pharmacology & Therapeutics ( IF 7.6 ) Pub Date : 2021-11-05 , DOI: 10.1111/apt.16685
Elisabetta Degasperi 1 , Riccardo Perbellini 1 , Roberta D'Ambrosio 1 , Sara Colonia Uceda Renteria 2 , Ferruccio Ceriotti 2 , Alberto Perego 3 , Corinna Orsini 3 , Marta Borghi 1 , Massimo Iavarone 1 , Mariangela Bruccoleri 1 , Alessandro Rimondi 1 , Annalisa De Silvestri 4 , Angelo Sangiovanni 1 , Pietro Lampertico 1, 5
Affiliation  

Prothrombin induced by vitamin K absence or antagonist-II (PIVKA-II) and alpha fetoprotein (AFP) are biomarkers for hepatocellular carcinoma (HCC). However, their performance in patients with cirrhosis related to hepatitis C virus (HCV) treated with direct-acting antiviral agents (DAA) is unknown.

中文翻译:

维生素 K 缺乏或拮抗剂-II 和甲胎蛋白诱导的凝血酶原可预测用直接作用抗病毒药物治疗的白种人丙型肝炎相关肝硬化患者的肝细胞癌发展

维生素 K 缺乏或拮抗剂-II (PIVKA-II) 和甲胎蛋白 (AFP) 诱导的凝血酶原是肝细胞癌 (HCC) 的生物标志物。然而,它们在接受直接作用抗病毒药物 (DAA) 治疗的丙型肝炎病毒 (HCV) 相关肝硬化患者中的表现尚不清楚。
更新日期:2021-11-05
down
wechat
bug